Evidence map›Paper›PMID 32494065›Full record

ArticleNature medicine2020

Publisher Correction: A clonal expression biomarker associates with lung cancer mortality.

Dhruva Biswas, Nicolai J Birkbak, Rachel Rosenthal, Crispin T Hiley, Emilia L Lim, Krisztian Papp, Stefan Boeing, Marcin Krzystanek, Dijana Djureinovic, Linnea La Fleur and 26 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Nature medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

36 authors.

Dhruva Biswas *Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, London, UK.
Nicolai J Birkbak *Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, London, UK. nbirkbak@clin.au.dk.ORCID http://orcid.org/0000-0003-1613-9587
Rachel RosenthalCancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, London, UK.
Crispin T HileyCancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, London, UK.
Emilia L LimCancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, London, UK.
Krisztian PappDepartment of Physics of Complex Systems, ELTE Eötvös Loránd University, Budapest, Hungary.ORCID http://orcid.org/0000-0003-0619-8233
Stefan BoeingBioinformatics and Biostatistics, The Francis Crick Institute, London, UK.
Marcin KrzystanekDanish Cancer Society Research Center, Copenhagen, Denmark.
Dijana DjureinovicDepartment of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
Linnea La FleurDepartment of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
Maria GrecoGenomics Equipment Park, The Francis Crick Institute, London, UK.
Balázs DömeDepartment of Tumor Biology, National Korányi Institute of Pulmonology, Semmelweis University, Budapest, Hungary.
János FillingerDepartment of Pathology, National Korányi Institute of Pulmonology, Semmelweis University, Budapest, Hungary.
Hans BrunnströmLund University, Laboratory Medicine Region Skåne, Department of Clinical Sciences Lund, Pathology, Lund, Sweden.ORCID http://orcid.org/0000-0001-7402-138X
Yin WuCancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, London, UK.
David A MooreDepartment of Pathology, UCL Cancer Institute, London, UK.
Marcin SkrzypskiCancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, London, UK.
Christopher AbboshCancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, London, UK.
Kevin LitchfieldCancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
Maise Al BakirCancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
Thomas B K WatkinsCancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
Selvaraju VeeriahCancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, London, UK.
Gareth A WilsonCancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, London, UK.
Mariam Jamal-HanjaniCancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, London, UK.
Judit MoldvayDepartment of Tumor Biology, National Korányi Institute of Pulmonology, Semmelweis University, Budapest, Hungary.
Johan BotlingDepartment of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
Arul M ChinnaiyanMichigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA.
Patrick MickeDepartment of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
Allan HackshawCancer Research UK & University College London Cancer Trials Centre, University College London, London, UK.
Jiri BartekDanish Cancer Society Research Center, Copenhagen, Denmark.
Istvan CsabaiDepartment of Physics of Complex Systems, ELTE Eötvös Loránd University, Budapest, Hungary.
Zoltan SzallasiDanish Cancer Society Research Center, Copenhagen, Denmark.
Javier HerreroBill Lyons Informatics Centre, University College London Cancer Institute, Paul O'Gorman Building, London, UK.ORCID http://orcid.org/0000-0001-7313-717X
Nicholas McGranahanCancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, London, UK. nicholas.mcgranahan.10@ucl.ac.uk.ORCID http://orcid.org/0000-0001-9537-4045
Charles SwantonCancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, London, UK. charles.swanton@crick.ac.uk.ORCID http://orcid.org/0000-0002-4299-3018
TRACERx Consortium

Funding

Cancer Research UK 17786Cancer Research UK 20764Cancer Research UK 21999Cancer Research UK 22246Cancer Research UK 28990Cancer Research UK 29420Cancer Research UK 29569Cancer Research UK 30025
6 · The paper itself

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiers

PMID32494065

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.